Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05275231 · ClinicalTrials.gov registry record · NA

Better Together Study

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
108
Enrollment target

NCT05275231: Completed NA study, sponsored by Emory University.

NCT05275231 is a NA study that has completed, run by Emory University. The registered enrollment target is 108 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05275231, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
108 participants
Enrollment target

Study Summary

This study (Aim 1) seeks to test that a culturally-tailored lifestyle intervention is feasible and acceptable for immigrant men from South Asia and West Africa. This will be a pre-post pilot study of a 16-week lifestyle program for South Asians and West Africans with prediabetes or diabetes in Atlanta. Patients will participate in health-professional-led group visits every other week focused on improving dietary and exercise practices to reduce weight. Groups will be followed at baseline, 4 months and 12 months. Groups will be separated by region of origin (i.e. separate groups for South Asians and West Africans). For Aim 2,the study team will assess intervention spillover effects among participant's self-identified social networks. The study team will ask participants in Aim 1 to name 5 people in their social networks to participate in a survey of health behaviors at baseline and 12-months to assess health behavior practices.

Primary Outcome

Which group of the study are participants choosing between the single participant group or the dyad. Preferences will be assessed by quantifying number enrolled in each group.

Interventions

  • BEHAVIORAL Intensive lifestyle interventions (ILIs)

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2022-04-04
Est. Completion 2024-01-01
Phase NA
Emory University

1,208 total trials

What the finished NCT05275231 record still lists

NCT05275231 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which Intensive lifestyle interventions (ILIs) is the first listed.

NCT05275231 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05275231 about?

NCT05275231 is a clinical study titled "Better Together Study". This study (Aim 1) seeks to test that a culturally-tailored lifestyle intervention is feasible and acceptable for immigrant men from South Asia and West Africa. This will be a pre-post pilot study of a 16-week lifestyle program for South Asians and West Africans with prediabetes or diabetes in Atlan...

What is the current status of trial NCT05275231?

This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2022-04-04. Estimated completion is 2024-01-01.

What interventions are being tested in trial NCT05275231?

The interventions under investigation include: Intensive lifestyle interventions (ILIs) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05275231?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05275231's enrollment target sits among peer trials

108 825th of 2000 higher than 1,171 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05275231, the US trial registry maintained by the National Library of Medicine. NCT05275231 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.